亮丙瑞林微球治療子宮內(nèi)膜異位癥患者的臨床效果分析
打開文本圖片集
【摘要】目的:分析亮丙瑞林微球治療子宮內(nèi)膜異位癥患者對內(nèi)分泌指標(biāo)、不良反應(yīng)的影響。方法:選取本院于2020年2月—2023年2月收治的82例子宮內(nèi)膜異位癥患者作為此次研究對象,對照組采用孕三烯酮膠囊治療,實(shí)驗(yàn)組在對照組基礎(chǔ)上采用亮丙瑞林微球治療,比較兩組治療效果。結(jié)果:實(shí)驗(yàn)組治療總有效率(95.12%)高于對照組(75.61%)(P
【關(guān)鍵詞】子宮內(nèi)膜異位癥;亮丙瑞林微球;臨床效果
Clinical efficacy analysis of leuprorelin microspheres in the treatment of patients with endometriosis
ZAN Qing
Obstetrics and Gynecology Department of the 943rd Hospital of the Joint Logistics Support Force, Wuwei, Gansu 733000, China
【Abstract】Objective:To analyze the effects of leuprorelin microspheres on endocrine indicators and adverse reactions in patients with endometriosis.Methods:82 patients with endometriosis admitted to our hospital from February 2020 to February 2023 were selected as the study subjects.The control group was treated with gestrinone capsules,while the experimental group was treated with leuprorelin microspheres on the basis of the control group.The treatment effects of the two groups were compared.Results:The total effective rate of the experimental group (95.12%) was higher than that of the control group (75.61%) (P
【Key?Words】Endometriosis; Leuprorelin microspheres; Clinical effects
子宮內(nèi)膜異位癥是臨床婦科常見疾病,其發(fā)生與免疫、遺傳、炎癥等因素相關(guān)[1-2],臨床多表現(xiàn)為疼痛、月經(jīng)異常。(剩余4882字)